TP53 and neoplasm: DACH1 suppresses tumor progression by inhibiting cell proliferation, reversing oncogenic pathway-mediated malignant phenotypes of epithelial cells, hampering cell migration and invasion, reducing tumor stemness, inhibiting Forkhead signaling pathway, and enhancing the activity of p53 pathway [40–47].